Literature DB >> 31864888

Local anesthetic pain catheters to reduce opioid use in massive weight loss patients undergoing abdominoplasty: A comparative study.

Salvatore Giordano1, Panu Uusalo2, Carlo M Oranges3, Pietro G di Summa4, Petteri Lankinen5.   

Abstract

BACKGROUND: Abdominoplasty is a common procedure for anatomical restoration of the lower abdominal skin, with a continuously increasing annual number of procedures performed. The significance of postoperative pain management is of crucial importance from a patient's perspective and to ensure the achievement of the aimed clinical outcome. We evaluated the efficacy of local pain pump catheters (PPCs) on massive weight loss patients undergoing body-contouring abdominoplasty.
METHODS: Primary abdominoplasty procedures after massive weight loss performed from 2009 to 2014 were retrospectively reviewed. The patients were divided into two groups according to the use of the PPC. The primary outcome measure was the amount of opioid use calculated as morphine equivalents. The secondary outcome measures were the length of hospital stay (LOS) and early postoperative complications within 30 days of surgery.
RESULTS: A total of 61 patients were included in the study: 24 patients in the PPC group and 37 patients in the conventional abdominoplasty analgesia (CAA) group. No significant differences between the study groups were found with regard to demographics, operative time, and resection weight. A significantly decreased use of opioids was observed after using PPC versus control (14.0 ± 13.9 mg vs. 74.6 ± 73.3 mg, p < 0.001). Similarly, the LOS was shorter in the PPC group (3.1 ± 1.1 days vs. 3.8 ± 1.0 days, p = 0.023). There was a similar rate of complications in both groups (45.8% vs. 40.5%, p = 0.622). The most common complication was seroma formation (25.0% vs. 18.5%, p = 0.315).
CONCLUSION: The use of local anesthetic pain catheters in abdominoplasty may be associated with a decreased use of opioids and might result in a shorter hospital stay on massive weight loss patients. Further studies are needed to validate this treatment modality.
Copyright © 2019 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Abdominoplasty, Obesity, Weight loss; Pain management; Pain pump

Mesh:

Substances:

Year:  2019        PMID: 31864888     DOI: 10.1016/j.bjps.2019.11.003

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  3 in total

1.  Analgesic Effect of Ropivacaine Pumped in the Sub Rectus Abdominis Muscle Sheath after Abdominoplasty.

Authors:  Sainan Wu; Richard Lung; Ningjin Wu; Ji Jin
Journal:  Aesthetic Plast Surg       Date:  2022-05-05       Impact factor: 2.708

Review 2.  The Global Prevalence of Seroma After Abdominoplasty: A Systematic Review and Meta-Analysis.

Authors:  Nader Salari; Behnaz Fatahi; Yalda Bartina; Mohsen Kazeminia; Mohammadbagher Heydari; Masoud Mohammadi; Mahvan Hemmati; Shamarina Shohaimi
Journal:  Aesthetic Plast Surg       Date:  2021-06-02       Impact factor: 2.708

3.  Evaluating the Efficacy of Two Regional Pain Management Modalities in Autologous Breast Reconstruction.

Authors:  Juan L Rendon; Jaume Borrell-Vega; Joshua-Paolo C Reyes; Diana M Wang; Cory Roeth; Mahmoud Abdel-Rasoul; Roman J Skoracki; Ronald L Harter; Susan D Moffatt-Bruce; Michelle L Humeidan
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-01-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.